Lukas Leitner

Increased Adipocyte O2 Consumption Triggers HIF-1α, Causing Inflammation and Insulin Resistance in Obesity

Pro-resolving lipid mediators are leads for resolution physiology

Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases

Four Decades of Shigellosis in Israel: Epidemiology of a Growing Public Health Problem

Genomic and epigenomic regulation of adipose tissue inflammation in obesity

The Global Epidemic of the Metabolic Syndrome

Inflammation and tumor progression: signaling pathways and targeted intervention

Susceptibility to chronic inflammation: an update

Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review

Nonalcoholic Fatty Liver Disease, Hepatic Insulin Resistance, and Type 2 Diabetes

Inflammation, metaflammation and immunometabolic disorders

Specialized pro-resolving mediators: endogenous regulators of infection and inflammation

Inflammation in obesity, diabetes, and related disorders

Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity

Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease

Treatment with n-3 Polyunsaturated Fatty Acids Overcomes the Inverse Association of Vitamin D Deficiency with Inflammation in Severely Obese Patients: A Randomized Controlled Trial

Transcriptional Cofactor TBLR1 Controls Lipid Mobilization in White Adipose Tissue

Impaired Local Production of Proresolving Lipid Mediators in Obesity and 17-HDHA as a Potential Treatment for Obesity-Associated Inflammation

An outbreak of typhoid fever due to contamination of the municipal water supply in northern Israel.